Although a trend towards a lower incidence of BPH-related surgery was seen in the alfuzosin group, this did not reach statistical significance when compared with the placebo group [ 6 ].
← all excerpts
Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia.
1
—
—